Home>
US Stocks>
Checkpoint Therapeutics

Checkpoint Therapeutics share price today

(CKPT)

Checkpoint Therapeutics share price is $3.64 & ₹310.12 as on 25 Dec 2024, 2.30 'hrs' IST

$3.64

▲

0.1

(2.82%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Checkpoint Therapeutics share price in Dollar and Rupees. Guide to invest in Checkpoint Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Checkpoint Therapeutics. Get details on the Indian mutual funds that are investing in Checkpoint Therapeutics. Get Analyst recommendations and forecasts along with all the Checkpoint Therapeutics's financials.

Checkpoint Therapeutics share price movements

Today's Low: $3.41
Today's High: $3.65
$3.64
6.32%
Downside
Day's Volatility :6.57%
Upside
0.27%
52 Weeks Low: $1.38
52 Weeks High: $4.50
$3.64
62.09%
Downside
52 Weeks Volatility :69.33%
Upside
19.11%

Checkpoint Therapeutics Returns

Period	Checkpoint Therapeutics Inc	Index (Russel 2000)
3 Months	63.23%	0.0%
6 Months	76.7%	0.0%
1 Year	66.97%	0.0%
3 Years	-88.03%	-21.1%

Checkpoint Therapeutics Key Statistics

in dollars & INR

Previous Close	$3.54
Open	$3.52
Today's High	$3.65
Today's Low	$3.4101
Market Capitalization	$177.8M
Today's Volume	$502.9K
52 Week High	$4.5
52 Week Low	$1.38
Revenue TTM	$78.0K
Earnings Per Share (EPS)	$-1.83
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-1220.38%

How to invest in Checkpoint Therapeutics from India?

It is very easy for Indian residents to invest directly in Checkpoint Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Checkpoint Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Checkpoint Therapeutics or CKPT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Checkpoint Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Checkpoint Therapeutics shares which would translate to 0.234 fractional shares of Checkpoint Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Checkpoint Therapeutics, in just a few clicks!

Returns in Checkpoint Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Checkpoint Therapeutics investment value today

Current value as on today

₹1,69,211

Returns

₹69,211

(+69.21%)

Returns from Checkpoint Therapeutics Stock

₹66,972 (+66.97%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Checkpoint Therapeutics

158%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Checkpoint Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 158% more investors are searching Checkpoint Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Checkpoint Therapeutics

Armistice Capital, LLC
7.96%
Vanguard Group Inc
2.81%
Geode Capital Management, LLC
0.88%
National Asset Management Inc
0.47%
BlackRock Inc
0.42%
Wealth Enhancement Advisory Services, LLC
0.27%

Analyst Recommendation on Checkpoint Therapeutics

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Checkpoint Therapeutics(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Checkpoint Therapeutics

What analysts predicted

Upside of 394.51%

Current:

$3.64

Target:

$18.00

Insights on Checkpoint Therapeutics

Price Movement
In the last 3 months, CKPT stock has moved up by 63.2%
Increasing Revenue
Revenue is up for the last 2 quarters, 6.0K → 41.0K (in $), with an average increase of 85.4% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -6.67M → -9.72M (in $), with an average decrease of 45.8% per quarter
CKPT vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 113.5%

Checkpoint Therapeutics Technicals Summary

Sell

Neutral

Buy

Checkpoint Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Checkpoint Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Checkpoint Therapeutics Inc	-11.22%	76.7%	66.97%	-88.03%	-78.2%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Checkpoint Therapeutics Inc	NA	NA	0.0	0.0	-12.2	-3.17	NA	-0.47
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Checkpoint Therapeutics Inc	Buy	$177.8M	-78.2%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Checkpoint Therapeutics

checkpoint therapeutics, inc., an immuno-oncology biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. the company's product candidates include ck-101 that in phase i clinical trial for the treatment of epidermal growth factor receptor mutation-positive non-small cell lung cancer; and cosibelimab, a programmed death ligand-1 (pd-l1), which is in phase i clinical trial in patients with selected recurrent or metastatic cancers. it also develops ck-103, a small molecule inhibitor of bet bromodomains; and ck-302, a human agonistic antibody for oncology indications. checkpoint therapeutics, inc. has collaboration agreements with tg therapeutics, inc. to develop and commercialize certain assets in connection with its licenses in the field of hematological malignancies. the company was founded in 2014 and is headquartered in new york, new york. checkpoint therapeutics, inc. is a subsidiary of fortr

Organization	Checkpoint Therapeutics
Employees	23
CEO	Mr. James F. Oliviero III, C.F.A.
Industry	Health Technology

Management People of Checkpoint Therapeutics

Name	Title
Mr. James F. Oliviero III, C.F.A.	President, CEO & Director

Important FAQs about investing in Checkpoint Therapeutics from India :

What is Checkpoint Therapeutics share price today?

Checkpoint Therapeutics share price today stands at $3.64, Open: $3.52 ; Previous Close: $3.54 ; High: $3.65 ; Low: $3.41 ; 52 Week High: $4.50 ; 52 Week Low: $1.38. The stock opens at $3.52, after a previous close of $3.54. The stock reached a daily high of $3.65 and a low of $3.41, with a 52-week high of $4.50 and a 52-week low of $1.38.

Can Indians buy Checkpoint Therapeutics shares?

Yes, Indians can invest in the Checkpoint Therapeutics (CKPT) from India.

With INDmoney, you can buy Checkpoint Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Checkpoint Therapeutics at zero transaction cost.

How can I buy Checkpoint Therapeutics shares from India?

It is very easy to buy Checkpoint Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Checkpoint Therapeutics be purchased?

Yes, you can buy fractional shares of Checkpoint Therapeutics with INDmoney app.

What are the documents required to start investing in Checkpoint Therapeutics stocks?

To start investing in Checkpoint Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.